2017-12-12 15:46:28 | Vital Therapies up 15% after insider purchase and addition to NBIYesterday after the close, Vital Therapies disclosed in a filing that director/investor Muneer Satter added to his stake with a purchase of 150K shares. Earlier, the stock was also added to the NASDAQ Biotechnology Index, which will become effective prior to the open of U.S. markets Monday, December 18, 2017. |
---|